Error: Could not add to watchlist. X
+ Watchlist

Talon Therapeutics Inc

TLON:US
Acquired
TLON:US was acquired by SPPI:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.810
Market Cap (USD)
-
Shares Outstanding (m)
22.012
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Talon Therapeutics Inc. is a biopharmaceutical company dedicated to developing and commercializing cancer therapies. The Company's lead product candidate potentially treats acute lymphoblastic leukemia and lymphomas.
Address
400 Oyster Point Blvd.
Suite 200
San Francisco, CA 94080
United States
Phone
1-650-588-6404
Show More